BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21680150)

  • 21. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
    Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
    Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of familially associated cherubism, centro-osseous giant cell granulomas and giant cell tumors of the jaws].
    Wechsler J; Grellet M
    Rev Stomatol Chir Maxillofac; 1984; 85(4):337-40. PubMed ID: 6593801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
    Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
    Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
    Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
    Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
    Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life.
    Prescott T; Redfors M; Rustad CF; Eiklid KL; Geirdal AØ; Storhaug K; Jensen JL
    Eur J Med Genet; 2013 Mar; 56(3):131-7. PubMed ID: 23298620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
    Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
    Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
    Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
    Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
    Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic profiling of central giant cell granuloma of the jaws.
    Carinci F; Piattelli A; Martinelli M; Palmieri A; Rubini C; Fioroni M; Scapoli L; Laino G; Caputi S; Becchetti A; Pezzetti F
    J Craniofac Surg; 2005 May; 16(3):399-407. PubMed ID: 15915104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cherubism. A case report.
    Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
    Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Cherubism": familial, multilocated cystic jawbone changes due to giant-cell granulomas].
    Seeliger G; Meister P
    ZWR; 1976 Apr; 85(8):369-72. PubMed ID: 1066907
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
    Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
    Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cherubism: best clinical practice.
    Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular cannibalism in central and peripheral giant cell granuloma of the oral cavity can predict biological behavior of the lesion.
    Sarode SC; Sarode GS
    J Oral Pathol Med; 2014 Jul; 43(6):459-63. PubMed ID: 24112367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.